J. David Port

6.0k total citations
92 papers, 4.6k citations indexed

About

J. David Port is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. David Port has authored 92 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 28 papers in Cardiology and Cardiovascular Medicine and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. David Port's work include Receptor Mechanisms and Signaling (39 papers), Cardiac electrophysiology and arrhythmias (12 papers) and RNA Research and Splicing (12 papers). J. David Port is often cited by papers focused on Receptor Mechanisms and Signaling (39 papers), Cardiac electrophysiology and arrhythmias (12 papers) and RNA Research and Splicing (12 papers). J. David Port collaborates with scholars based in United States, Italy and Spain. J. David Port's co-authors include Michael R. Bristow, Wayne Minobe, Ray E. Hershberger, C C Malbon, Carmen C. Sucharov, R Rasmussen, Arthur M. Feldman, Robert L. Roden, Burns C. Blaxall and Patricia S. Larrabee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

J. David Port

91 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. David Port United States	33	2.7k	2.3k	573	426	374	92	4.6k
Elizabeth A. Woodcock Australia	36	2.6k 1.0×	1.9k 0.8×	485 0.8×	514 1.2×	260 0.7×	146	4.1k
Andrea D. Eckhart United States	38	2.7k 1.0×	1.5k 0.7×	564 1.0×	513 1.2×	241 0.6×	66	3.7k
Lan Mao United States	39	2.5k 0.9×	2.1k 0.9×	389 0.7×	687 1.6×	409 1.1×	84	5.1k
Robert H. G. Schwinger Germany	44	3.5k 1.3×	4.0k 1.8×	741 1.3×	527 1.2×	728 1.9×	203	6.5k
Wayne Minobe United States	31	3.7k 1.4×	5.3k 2.3×	622 1.1×	733 1.7×	695 1.9×	49	7.6k
Douglas G. Tilley United States	34	2.3k 0.9×	1.2k 0.5×	690 1.2×	383 0.9×	293 0.8×	86	3.4k
Anastasios Lymperopoulos United States	34	2.1k 0.8×	1.7k 0.7×	685 1.2×	392 0.9×	290 0.8×	112	3.4k
Rui-Ping Xiao United States	31	3.3k 1.2×	2.2k 1.0×	882 1.5×	368 0.9×	158 0.4×	44	4.2k
Harvey S. Hahn United States	28	2.5k 0.9×	2.1k 0.9×	292 0.5×	374 0.9×	267 0.7×	47	3.8k
Timothy D. O’Connell United States	28	1.5k 0.6×	924 0.4×	306 0.5×	284 0.7×	298 0.8×	60	2.7k

Countries citing papers authored by J. David Port

Since Specialization

Citations

This map shows the geographic impact of J. David Port's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. David Port with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. David Port more than expected).

Fields of papers citing papers by J. David Port

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. David Port. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. David Port. The network helps show where J. David Port may publish in the future.

Co-authorship network of co-authors of J. David Port

This figure shows the co-authorship network connecting the top 25 collaborators of J. David Port. A scholar is included among the top collaborators of J. David Port based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. David Port. J. David Port is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aleong, Ryan G., William H. Sauer, Gordon Davis, et al.. (2013). Prevention of Atrial Fibrillation by Bucindolol Is Dependent on the Beta 1 389 Arg/Gly Adrenergic Receptor Polymorphism. JACC Heart Failure. 1(4). 338–344. 41 indexed citations

Taylor, Molly A., et al.. (2010). Intracellular localization and interaction of mRNA binding proteins as detected by FRET. BMC Cell Biology. 11(1). 69–69. 17 indexed citations

Port, J. David & Carmen C. Sucharov. (2010). Role of MicroRNAs in Cardiovascular Disease: Therapeutic Challenges and Potentials. Journal of Cardiovascular Pharmacology. 56(5). 444–453. 45 indexed citations

Sucharov, Carmen C., Michael R. Bristow, & J. David Port. (2008). miRNA expression in the failing human heart: Functional correlates. Journal of Molecular and Cellular Cardiology. 45(2). 185–192. 200 indexed citations

Vest, Rebekah S., Kurtis D. Davies, Heather O’Leary, J. David Port, & K. Ulrich Bayer. (2007). Dual Mechanism of a Natural CaMKII Inhibitor. Molecular Biology of the Cell. 18(12). 5024–5033. 146 indexed citations

Blaxall, Burns C. & J. David Port. (2003). Determination of mRNA Stability and Characterization of Proteins Interacting with Adrenergic Receptor mRNAs. Humana Press eBooks. 126. 453–465. 4 indexed citations

Communal, Catherine, Wilson S. Colucci, Andréa Remondino, et al.. (2002). Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium. Journal of Cardiac Failure. 8(2). 86–92. 41 indexed citations

Port, J. David & Michael R. Bristow. (2001). Altered Beta-adrenergic Receptor Gene Regulation and Signaling in Chronic Heart Failure. Journal of Molecular and Cellular Cardiology. 33(5). 887–905. 211 indexed citations

Asano, Koji, et al.. (2001). Bucindolol, a Nonselective β1- and β2-Adrenergic Receptor Antagonist, Decreases β-Adrenergic Receptor Density in Cultured Embryonic Chick Cardiac Myocyte Membranes. Journal of Cardiovascular Pharmacology. 37(6). 678–691. 16 indexed citations

10.

Bisognano, John D., Howard D. Weinberger, Teresa Bohlmeyer, et al.. (2000). Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic Mice. Journal of Molecular and Cellular Cardiology. 32(5). 817–830. 205 indexed citations

11.

Port, J. David, et al.. (2000). Deactivation of the sympathetic nervous system in patients with chronic congestive heart failure. Current Cardiology Reports. 2(3). 225–232. 3 indexed citations

12.

Blaxall, Burns C., et al.. (2000). Purification and Characterization of β-Adrenergic Receptor mRNA-binding Proteins. Journal of Biological Chemistry. 275(6). 4290–4297. 50 indexed citations

13.

Blaxall, Burns C., et al.. (1998). Agonist-Mediated Destabilization of Human β1-adrenergic Receptor mRNA: Role of the 3′ Untranslated Translated Region. Biochemical and Biophysical Research Communications. 252(2). 357–362. 23 indexed citations

14.

Yoshikawa, Tsutomu, J. David Port, Koji Asano, et al.. (1996). Cardiac adrenergic receptor effects of carvedilol. European Heart Journal. 17(suppl B). 8–16. 146 indexed citations

15.

Bristow, Michael R., Wayne Minobe, M V Raynolds, et al.. (1993). Reduced beta 1 receptor messenger RNA abundance in the failing human heart.. Journal of Clinical Investigation. 92(6). 2737–2745. 191 indexed citations

16.

Anderson, Fred, J. David Port, B.B. Reid, et al.. (1992). Effect of Therapeutic Dopamine Administration on Myocardial Catecholamine and Neuropeptide Y Concentrations in the Failing Ventricles of Patients with Idiopathic Dilated Cardiomyopathy. Journal of Cardiovascular Pharmacology. 20(5). 800–806. 1 indexed citations

17.

Wollmering, Mary M., Robert J. Wiechmann, J. David Port, et al.. (1991). Dobutamine is a partial agonist with an intrinsic activity of 0.5 in human myocardium. Journal of the American College of Cardiology. 17(2). A283–A283. 6 indexed citations

18.

Port, J. David, et al.. (1990). Increased expression of β 2 -adrenergic receptors in surgically denervated, previously transplanted human ventricular myocardium. Journal of the American College of Cardiology. 15(2). A84–A84. 8 indexed citations

19.

Port, J. David, et al.. (1990). Cardiac donor heart dysfunction: Evidence for catecholamine-mediated myocardial injury. Journal of the American College of Cardiology. 15(2). A84–A84. 1 indexed citations

20.

Clark, Norman J., et al.. (1988). Preservation of the ischemic canine myocardium: A comparison of hypothermia, lidoflazine, and ketanserin. Journal of Cardiothoracic Anesthesia. 2(3). 330–340. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact